HCV感染者F蛋白抗体阳性检出率的Meta分析

doi:10.3969/j.issn.1673-8640.2013.11.009

检验医学 ›› 2013, Vol. 28 ›› Issue (11): 1001-1007.DOI: 10.3969/j.issn.1673-8640.2013.11.009

HCV感染者F蛋白抗体阳性检出率的Meta分析

刘婕¹，王嘉拾²，余文华³，张磊⁴，康华⁴，范志娟⁴，刘树业⁴

1.天津医科大学三中心临床学院检验科，天津 300170；
2.天津医科大学研究生院神经外科学，天津 300170；
3.天津医科大学公共卫生学院，天津 300170；
4.天津市第三中心医院检验科，天津 300170

收稿日期:2012-12-15 出版日期:2013-11-30 发布日期:2013-12-20
通讯作者: 刘树业，联系电话022-84112332。
作者简介:刘婕，女，1988年生，学士，主要从事肝胆疾病的代谢组学研究。

Meta analysis on the positive detection rate of anti-F protein antibodies in patients with HCV infection

LIU Jie¹, WANG Jiashi², YU Wenhua³, ZHANG Lei⁴, KANG Hua⁴, FAN Zhijuan⁴, LIU Shuye⁴.

1. Department of Clinical Laboratory, the Third Central Clinical College, Tianjin Medical University, Tianjin 300170, China;
2.Department of Neurosurgery, Graduate School, Tianjin Medical University, Tianjin 300170, China;
3.School of Public Health, Tianjin Medical University, Tianjin 300170, hina;
4.Department of Clinical Laboratory, the Third Central Hospital of Tianjin, Tianjin 300170, China

Received:2012-12-15 Online:2013-11-30 Published:2013-12-20

摘要/Abstract

摘要：

目的　采用Meta分析的方法探讨丙型肝炎病毒(HCV)感染者体内抗F蛋白循环抗体的产生。方法　检索1968年至2012年11月中国知网、万方数据库、万方医学网、维普、SinoMED、Medline、Pubmed、Splingerlink、Cochrane、Sciencedirect的相关文献，手工检索查全补充，严格根据纳入和排除标准筛选文献，将最终纳入文献采用Revman5.0软件进行数据合并与分析。采用OQAQ量表对结果进行评价。结果　HCV感染者与健康人群对照，共纳入14项病例对照研究，合计1348例HCV感染者，F蛋白抗体检出率差异有统计学意义(P<0.00001)，合并率的优势比>1，总体比值比(OR)达64.81[95%可信区间(CI)为29.90~140.49];HCV感染者与非HCV感染者对照，共纳入11项对照研究，合计923例HCV感染者，F蛋白抗体检出率差异有统计学意义(P<0.00001)，HCV感染者F蛋白检出率是非HCV感染者的53.09倍(95%CI为23.56~119.66);HCV感染者F蛋白抗体检出率与核心蛋白抗体检出率对照，共纳入8项对照研究，合计770例HCV感染者，差异有统计学意义(P<0.00001)，率差(RD)为-0.42(95%CI为-0.59~-0.25)，核心蛋白抗体检出率比F蛋白抗体高42%。结论　HCV感染者体内抗F蛋白抗体检出率明显高于健康人和非HCV感染者。F蛋白可诱导HCV感染者产生抗F蛋白特异性循环抗体，是HCV产生的特异蛋白，可为实验室诊断HCV感染和监测干扰素联合治疗HCV效果提供理论依据和数据支持。

关键词: Meta分析, F蛋白, 丙型肝炎病毒

Abstract:

Objective　To investigate the production of anti-F protein antibodies in patients with hepatitis C virus (HCV) infection by Meta analysis. Methods　Relative literatures were searched from the CNKI, Wan Fang, Weipu, SinoMED, Medline, Pubmed, Splingerlink, Cochrane and Science direct from 1968 to November 2012, and hand searching investigation was as complement. The literatures were selected according to the inclusion and exclusion criteria. The final literatures were consolidated and analyzed by Revman 5.0 software. The results were evaluated by Oxman-Guyatt Overview qualityassessment questionnaire (OQAQ). Results　The results of patients with HCV infection and healthy subjects were compared, and 14 studies with 1 348 patients with HCV infection were enrolled. The positive detection rate of anti-F protein antibodies had statistical significance (P<0.000 01). The superiority of pooled rate was>1. The total odds ratio (OR) was 64.81 [95% confidence interval (CI) 29.90-140.49]. The results of patients with HCV infection and non-HCV infection were compared, and 11 studies with 923 patients with HCV infection were enrolled. The positive detection rate of anti-F protein antibodies had statistical significance (P<0.000 01). The positive detection rate of patients with HCV infection was 53.09 times for that of patients with non-HCV infection (95% CI 23.56-119.66). By comparing the positive detection rate of anti-F protein antibodies with that of anti-core protein antibodies in patients with HCV infection, and 8 studies with 770 patients with HCV infection were enrolled, and there was statistical significance (P<0.000 01). The rate difference (RD) was -0.42 (95% CI -0.59--0.25).The positive detection rate of anti-core protein antibodies was 42%, which was higher than that of anti-F protein antibodies. Conclusions　The positive detection rate of anti-F protein antibodies in patients with HCV infection is significantly higher than those in healthy subjects and patients with non-HCV infection. F protein can induce HCV infection producing anti-F protein antibodies, which is a specific protein. It provides a theoretical basis and datum support for the diagnosis of HCV infection and monitoring the interferon combination therapy.

Key words: Meta analysis, F protein, Hepatitis C virus

中图分类号:

R446.62

刘婕，王嘉拾，余文华，张磊，康华，范志娟，刘树业. HCV感染者F蛋白抗体阳性检出率的Meta分析[J]. 检验医学, 2013, 28(11): 1001-1007.

LIU Jie, WANG Jiashi, YU Wenhua, ZHANG Lei, KANG Hua, FAN Zhijuan, LIU Shuye.. Meta analysis on the positive detection rate of anti-F protein antibodies in patients with HCV infection[J]. , 2013, 28(11): 1001-1007.

[1]	何鑫, 李燕平. 疾病类型和临床指标对CMIA抗HCV抗体检测的影响[J]. 检验医学, 2023, 38(3): 287-290.
[2]	陆银华, 朱宇清, 赵晓君, 曹丹如, 朱岭峰, 顾志冬. 不同检测系统抗HCV抗体灰区样本检测一致性分析[J]. 检验医学, 2021, 36(7): 700-704.
[3]	叶松道, 陈允国, 叶宣梅. 慢性丙型肝炎患者血浆IRF-3水平的变化及临床意义[J]. 检验医学, 2021, 36(5): 486-489.
[4]	江雅平, 李智慧, 李志艳, 王玎玲. 不同保存条件及反复冻融对血清HCV抗体检测的影响[J]. 检验医学, 2021, 36(10): 1060-1063.
[5]	李世超, 申梁, 王春花, 童艳飞, 张冀. SARS-CoV-2抗体用于COVID-19诊断的Meta分析[J]. 检验医学, 2021, 36(1): 39-43.
[6]	万文婷, 于波, 弓孟春, 史文钊, 郭昊, 杨杰. 循环肿瘤DNA对黑色素瘤诊断价值的Meta分析[J]. 检验医学, 2020, 35(8): 784-790.
[7]	张敏杰, 高玉芳, 杨飞飞, 徐晓莉. 中国人群传染性单核细胞增多症患者抗EB病毒抗体阳性检出率的Meta分析[J]. 检验医学, 2020, 35(3): 214-223.
[8]	李琳芸, 彭长华, 梅冰, 董莉. 中国人群强直性脊柱炎与ERAP-1基因多态性的相关性Meta分析[J]. 检验医学, 2018, 33(6): 481-485.
[9]	于宏亮. 慢性丙型肝炎患者sVAP-1与肝功能指标及血清HCVRNA载量的相关分析[J]. 检验医学, 2018, 33(3): 201-204.
[10]	李慧敏, 马清光, 李洪英. 胸腔积液γ-干扰素释放试验对结核性胸腔积液诊断价值的Meta分析[J]. 检验医学, 2018, 33(2): 139-146.
[11]	孙斌, 王姗, 钱俊, 唐振华. 63 109例上海地区孕妇部分产前筛查指标分析[J]. 检验医学, 2017, 32(5): 386-389.
[12]	姜树朋, 童永清, 李艳. 武汉地区丙型肝炎病毒基因型分布及其少见基因亚型系统进化树分析[J]. 检验医学, 2017, 32(10): 861-866.
[13]	陆银华, 蒋玲丽, 朱宇清, 徐翀, 赵晓君, 曹丹如, 朱岭峰, 顾志冬. 抗HCV抗体灰区样本的处置方案和产生原因分析及临床提示[J]. 检验医学, 2017, 32(1): 8-13.
[14]	黄秋兰, 范德平, 高守霞, 刘红绸, 薛娜丽, 倪语星. Ⅰ类整合子对铜绿假单胞菌亚胺培南耐药诊断价值的Meta分析[J]. 检验医学, 2016, 31(6): 491-498.
[15]	宋斌斌，周琰，吴文浩，吴炯，张春燕，王蓓丽，郭玮，潘柏申. 丙型肝炎患者HCV RNA载量、肝脏纤维化指数与25羟基维生素D水平的相关性分析[J]. 检验医学, 2015, 30(6): 575-580.

HCV感染者F蛋白抗体阳性检出率的Meta分析

Meta analysis on the positive detection rate of anti-F protein antibodies in patients with HCV infection

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics